We are live on
!
Find out more
GA
Geller Advisors Portfolio holdings
AUM
$1.52B
1-Year Est. Return
20.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+20.44%
5 Year Est. Return
+77.4%
10 Year Est. Return
+246.39%
AUM
$462M
AUM Growth
+$37.5M
(+8.8%)
Cap. Flow
+$2.56M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
85.89%
Holding
141
New
20
Increased
53
Reduced
52
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$6.6M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$3.04M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$807K |
| 4 |
Johnson & Johnson
JNJ
|
+$512K |
| 5 |
AstraZeneca
AZN
|
+$371K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NovoCure
NVCR
|
+$9.04M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.68M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$787K |
| 4 |
iShares MSCI KLD 400 Social ETF
DSI
|
+$342K |
| 5 |
ASML
ASML
|
+$60.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.41% |
| 2 | Financials | 2.74% |
| 3 | Healthcare | 2.6% |
| 4 | Communication Services | 2.01% |
| 5 | Consumer Discretionary | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
CME Group
CME
$92.2B
| $214K | 0.05% |
1,005
+6
| +0.6% | +$1.27K |
|
127
Illumina
ILMN
$29.4B
| $213K | 0.05% |
+463
| New | +$186K |
|
128
Walmart Inc
WMT
$871B
| $213K | 0.05% |
4,521
-12
| -0.3% | -$559 |
|
129
Quanta Services
PWR
$93.9B
| $211K | 0.05% |
+2,332
| New | +$219K |
|
130
MetLife
MET
$61B
| $208K | 0.05% |
3,468
+6
| +0.2% | +$380 |
|
131
Expedia Group
EXPE
$31.2B
| $207K | 0.04% |
+1,266
| New | +$217K |
|
132
Aflac
AFL
$63.9B
| $206K | 0.04% |
+3,842
| New | +$209K |
|
133
Cintas
CTAS
$82.4B
| $206K | 0.04% |
+2,152
| New | +$191K |
|
134
Regions Financial
RF
$26.3B
| $206K | 0.04% |
+10,161
| New | +$220K |
|
135
Xylem
XYL
$28.5B
| $206K | 0.04% |
+1,718
| New | +$196K |
|
136
Intercontinental Exchange
ICE
$82.4B
| $204K | 0.04% |
+1,720
| New | +$198K |
|
137
Revvity
RVTY
$12.3B
| $204K | 0.04% |
+1,323
| New | +$186K |
|
|
ATVI
138
DELISTED
Activision Blizzard
ATVI
| $204K | 0.04% |
+2,139
| New | +$203K |
|
139
Edwards Lifesciences
EW
$47.6B
| $203K | 0.04% |
+1,964
| New | +$185K |
|
140
KeyCorp
KEY
$24.3B
| $201K | 0.04% |
+9,730
| New | +$211K |
|
|
141
NovoCure
NVCR
$2.04B
| – | – |
-68,405
| Closed | -$9.04M |
|
Similar funds
ZB
IFLIT
MIIM
NIMI
EWM
CFGS
RDIA
WP
Geller Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Geller Advisors held 141 positions worth $462M, up 8.8% from $424M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Geller Advisors's Q2 2021 filing shows 20 new, 53 increased, 52 reduced and 1 closed positions. Its largest new stake was Vanguard Mid-Cap ETF: 113,804 shares worth $6.75M. The largest sale was NovoCure, an estimated $9.04M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 4.2% a quarter earlier, followed by Financials and Healthcare.
- Geller Advisors's largest Q2 2021 buy was Vanguard Mid-Cap ETF: 113,804 shares worth $6.75M.
- Geller Advisors added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $3.04M increase.
- Geller Advisors's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.68M.
- Geller Advisors fully exited NovoCure in Q2 2021, selling an estimated $9.04M.
- Geller Advisors's ten largest holdings make up 86% of its $462M portfolio in Q2 2021.
- Geller Advisors opened 20 new positions and closed 1 in Q2 2021.
- Geller Advisors's portfolio value rose 8.8% quarter-over-quarter to $462M.
Based on Geller Advisors's 13F filing for Q2 2021, filed 9 Aug 2021.